Who owns Pavmed?
- CUSIP Number: 70387r106
Tip: Access positions for across all investors
Analyze quarterly positions in Pavmed with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pavmed stock
Who bought or sold Pavmed this quarter?
There are no current stakeholders of Pavmed.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Pavmed?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Sep 2023 | 1.1M | $330k |
| First Manhattan | Sep 2023 | 1.0M | $295k |
| Geode Capital Management | Sep 2023 | 826k | $243k |
| XML Financial | Sep 2023 | 155k | $46k |
| Verition Fund Management | Sep 2023 | 141k | $42k |
| Northern Trust | Sep 2023 | 139k | $41k |
| Resources Investment Advisors | Sep 2023 | 125k | $37k |
| Group One Trading | Sep 2023 | 109k | $32k |
| LPL Financial | Sep 2023 | 97k | $29k |
| Lazari Capital Management | Sep 2023 | 89k | $26k |
| Susquehanna International | Sep 2023 | 67k | $19k |
| Morgan Stanley | Sep 2023 | 56k | $17k |
| Tower Research Capital | Sep 2023 | 52k | $15k |
| XTX Topco | Sep 2023 | 33k | $9.6k |
| Integrated Wealth Concepts | Sep 2023 | 25k | $7.4k |
| Gerber Kawasaki Wealth & Investment Management | Sep 2023 | 15k | $4.5k |
| Glenmede Trust Company | Sep 2023 | 15k | $4.4k |
| Atlantic Trust | Sep 2023 | 13k | $3.7k |
| Tobias Financial Advisors | Sep 2023 | 10k | $2.9k |
| M&r Capital Management | Sep 2023 | 1.0k | $295.000000 |
| FMR | Sep 2023 | 86.00 | $25.000200 |
| Qube Research & Technologies | Sep 2023 | 4.00 | $1.000000 |